TrimRx's Blog
Retatrutide vs Orforglipron: Power Versus Convenience
This comparison pits two very different philosophies against each other: retatrutide is the most powerful weight-loss drug in development (an injection), while orforglipron is…
Retatrutide vs CagriSema: The Two Most Powerful Pipeline Drugs Compared
If you’re tracking the highest-efficacy weight-loss drugs still in development, retatrutide and CagriSema are the two names that matter most, and retatrutide currently holds…
CagriSema vs Wegovy: How the Combo Compares to Semaglutide Alone
CagriSema takes Wegovy’s active ingredient and adds a second drug to it, and the result is more weight loss, though at the cost of…
Orforglipron vs Rybelsus: Comparing the Oral Weight Loss Pills
There’s an important catch to comparing orforglipron and Rybelsus: they’re not really competing for the same job. Orforglipron (Foundayo) is an oral pill approved…
VK2735: Comparing Viking’s Oral and Injectable Options
Viking Therapeutics is developing VK2735 in two forms, a weekly injection and a daily pill, and the practical difference comes down to convenience versus…
MariTide Results: How Much Weight Amgen’s Monthly Shot May Deliver
In its phase 2 trial, MariTide produced up to about 20% average weight loss over a year in people with obesity, and importantly, the…
Survodutide for MASH: Treating Fatty Liver Disease and Obesity Together
Survodutide is being studied for a serious liver disease called MASH (metabolic dysfunction-associated steatohepatitis), and its early results are among the most promising in…
Is Orforglipron FDA Approved Yet? Timeline and What to Expect
Yes. Orforglipron was approved by the FDA on April 1, 2026, and is sold under the brand name Foundayo. It’s approved for adults with…
Orforglipron Side Effects: What Early Studies Report
Orforglipron, now FDA approved and sold as Foundayo, has a side-effect profile that looks a lot like injectable GLP-1 drugs despite being a pill:…
